87 related articles for article (PubMed ID: 10959160)
1. [PHARAO Study of the Hypertension League. Can development of hypertension be prevented with drugs?].
MMW Fortschr Med; 2000 Jul; 142(28-29):35-6. PubMed ID: 10959160
[No Abstract] [Full Text] [Related]
2. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
[TBL] [Abstract][Full Text] [Related]
3. [ACE inhibitor therapy until end of life?].
Werner N
Dtsch Med Wochenschr; 2004 Oct; 129(44):2375-6. PubMed ID: 15497110
[No Abstract] [Full Text] [Related]
4. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial).
Joshi SR; Yeolekar ME; Tripathi KK; Giri J; Maity AK; Chopda M; Gujarathi S; Maroli S; Maity A;
J Assoc Physicians India; 2004 Mar; 52():189-95. PubMed ID: 15636307
[TBL] [Abstract][Full Text] [Related]
6. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL
J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
Uresin Y; Taylor AA; Kilo C; Tschöpe D; Santonastaso M; Ibram G; Fang H; Satlin A
J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
[TBL] [Abstract][Full Text] [Related]
9. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
10. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP
Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
[TBL] [Abstract][Full Text] [Related]
11. [In high risk patients also treat high normal blood pressure values!].
Düsing R
MMW Fortschr Med; 2006 Mar; 148(13):5. PubMed ID: 16642693
[No Abstract] [Full Text] [Related]
12. [Preventing hypertension with drugs?].
MMW Fortschr Med; 2006 Mar; 148(13):4-5. PubMed ID: 16642692
[No Abstract] [Full Text] [Related]
13. What should be the goal blood pressure?
Bulpitt CJ
J Hum Hypertens; 2001 Dec; 15(12):831-2. PubMed ID: 11773983
[No Abstract] [Full Text] [Related]
14. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.
Hathial M
Indian Heart J; 2008; 60(3):200-4. PubMed ID: 19240307
[TBL] [Abstract][Full Text] [Related]
16. Initiation of hypertension treatment with a fixed-dose combination or its monocomponents -- does it really matter?
Scholze J; Bida M; Hansen A; Juncken D; Rangoonwala B; Ritz A; Schnitker J; Dörffel Y
Int J Clin Pract; 2006 Mar; 60(3):265-74. PubMed ID: 16494640
[TBL] [Abstract][Full Text] [Related]
17. [7 causes of therapy refractory hypertension].
Schumacher B
MMW Fortschr Med; 2006 Mar; 148(13):6, 8. PubMed ID: 16642694
[No Abstract] [Full Text] [Related]
18. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive pulse waveform analysis in clinical trials: similarity of two methods for calculating aortic systolic pressure.
Adji A; Hirata K; Hoegler S; O'Rourke MF
Am J Hypertens; 2007 Aug; 20(8):917-22. PubMed ID: 17679043
[TBL] [Abstract][Full Text] [Related]
20. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
Schrader J; Lüders S; Kulschewski A; Hammersen F; Züchner C; Venneklaas U; Schrandt G; Schnieders M; Rangoonwala B; Berger J; Dominiak P; Zidek W;
J Hypertens; 2006 Mar; 24(3):541-8. PubMed ID: 16467658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
